The impact of tangeretin combined with whey protein on exercise-induced bronchoconstriction in professional athletes: a placebo-controlled trial
Background Exercise-induced bronchoconstriction (EIB) is highly prevalent in athletes. The objective of this study was to assess the therapeutic efficacy of daily tangeretin combined with whey protein supplementation over a period of 4 weeks in professional athletes with EIB.Methods Using a placebo-...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Journal of the International Society of Sports Nutrition |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/15502783.2024.2414870 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850124231666302976 |
|---|---|
| author | Zhi Cao Can Zhao Shiwei Mo Bing-Hong Gao Meng Liu |
| author_facet | Zhi Cao Can Zhao Shiwei Mo Bing-Hong Gao Meng Liu |
| author_sort | Zhi Cao |
| collection | DOAJ |
| description | Background Exercise-induced bronchoconstriction (EIB) is highly prevalent in athletes. The objective of this study was to assess the therapeutic efficacy of daily tangeretin combined with whey protein supplementation over a period of 4 weeks in professional athletes with EIB.Methods Using a placebo-controlled, double-blind, paired, randomized trial design, a cohort of 30 professional athletes with EIB, consisting of 14 females and 16 males, was divided into two groups: the tangeretin combined with whey protein intervention group (TIG), and the placebo control group (PCG). Both the TIG and PCG underwent exercise challenge tests (ECT) and VO2max tests before (ECT1, V1) and after (ECT2, V2) the intervention. Blood (eosinophils, neutrophils, and basophils) and serum (interleukin-5, IL-5; interleukin-8, IL-8; Clara cell secretory protein-16, CC16; immunoglobulin E, IgE) levels were measured early in the morning of ECT1 and ECT2, respectively. Lung function was assessed immediately before and post-ECT immediately.Results Tangeretin combined with whey protein use for 4 weeks attenuated the decrease in forced expiratory volume in 1 s (FEV1) post trials (∆FEV1(ECT1-ECT2): mean (SD) TIG −7.51(6.9)% vs. PCG −2.33(11.49)%, p = 0.013). Tangeretin also substantially attenuated IL-5 concentration (∆IL-5(T1-T5): Tangeretin −19.4% vs Placebo + 8.37%, p = 0.022); IL-8 concentration (∆IL-8(T1-T5): Tangeretin −17.28% vs Placebo + 6.1%, p = 0.012); CC16 concentration (∆CC16(T1-T5): Tangeretin −11.77% vs Placebo + 24.19%); and IgE concentration in the serum (∆IgE(T1-T5): Tangeretin −24.1% vs Placebo −3.9%), and significantly decreased neutrophil count (∆N(T1-T5): Tangeretin −11.34% vs Placebo + 0.3%) and eosinophil count in blood (∆N(T1-T5): Tangeretin −38.5% vs Placebo + 4.35%). Compared with V1, VO2max (p = 0.042) and TLim (p = 0.05) of V2 were significantly increased in the TIG, and there was no significant change in the PCG. Meanwhile, six athletes in the TIG and 0 athletes in the PCG became EIB-negative at ECT2; the overall negative conversion rate of EIB was 40.00% in TCG. Additionally, the number of cough symptoms decreased from 9 to 3 and dyspnea from 4 to 2 in the TIG.Conclusion After high-intensity exercise, athletes with EIB achieved significant improvements in lung function and blood inflammatory factors by combining tangeretin and whey protein supplementation. EIB athletes also showed longer exercise endurance and VO2max at 4 weeks after TI. In addition, some patient symptoms disappeared after combination supplementation. The effect of this treatment on professional athletes with EIB was beneficial. |
| format | Article |
| id | doaj-art-9b427a9ed4d3440bb962f444a8eeb681 |
| institution | OA Journals |
| issn | 1550-2783 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Journal of the International Society of Sports Nutrition |
| spelling | doaj-art-9b427a9ed4d3440bb962f444a8eeb6812025-08-20T02:34:23ZengTaylor & Francis GroupJournal of the International Society of Sports Nutrition1550-27832024-12-0121110.1080/15502783.2024.2414870The impact of tangeretin combined with whey protein on exercise-induced bronchoconstriction in professional athletes: a placebo-controlled trialZhi Cao0Can Zhao1Shiwei Mo2Bing-Hong Gao3Meng Liu4Shanghai University of Sport, School of Athletic Performance, Shanghai, ChinaShanghai University of Sport, School of Athletic Performance, Shanghai, ChinaShenzhen University, School of Physical Education, Shenzhen, ChinaShanghai University of Sport, School of Athletic Performance, Shanghai, ChinaChongqing University, Chongqing, ChinaBackground Exercise-induced bronchoconstriction (EIB) is highly prevalent in athletes. The objective of this study was to assess the therapeutic efficacy of daily tangeretin combined with whey protein supplementation over a period of 4 weeks in professional athletes with EIB.Methods Using a placebo-controlled, double-blind, paired, randomized trial design, a cohort of 30 professional athletes with EIB, consisting of 14 females and 16 males, was divided into two groups: the tangeretin combined with whey protein intervention group (TIG), and the placebo control group (PCG). Both the TIG and PCG underwent exercise challenge tests (ECT) and VO2max tests before (ECT1, V1) and after (ECT2, V2) the intervention. Blood (eosinophils, neutrophils, and basophils) and serum (interleukin-5, IL-5; interleukin-8, IL-8; Clara cell secretory protein-16, CC16; immunoglobulin E, IgE) levels were measured early in the morning of ECT1 and ECT2, respectively. Lung function was assessed immediately before and post-ECT immediately.Results Tangeretin combined with whey protein use for 4 weeks attenuated the decrease in forced expiratory volume in 1 s (FEV1) post trials (∆FEV1(ECT1-ECT2): mean (SD) TIG −7.51(6.9)% vs. PCG −2.33(11.49)%, p = 0.013). Tangeretin also substantially attenuated IL-5 concentration (∆IL-5(T1-T5): Tangeretin −19.4% vs Placebo + 8.37%, p = 0.022); IL-8 concentration (∆IL-8(T1-T5): Tangeretin −17.28% vs Placebo + 6.1%, p = 0.012); CC16 concentration (∆CC16(T1-T5): Tangeretin −11.77% vs Placebo + 24.19%); and IgE concentration in the serum (∆IgE(T1-T5): Tangeretin −24.1% vs Placebo −3.9%), and significantly decreased neutrophil count (∆N(T1-T5): Tangeretin −11.34% vs Placebo + 0.3%) and eosinophil count in blood (∆N(T1-T5): Tangeretin −38.5% vs Placebo + 4.35%). Compared with V1, VO2max (p = 0.042) and TLim (p = 0.05) of V2 were significantly increased in the TIG, and there was no significant change in the PCG. Meanwhile, six athletes in the TIG and 0 athletes in the PCG became EIB-negative at ECT2; the overall negative conversion rate of EIB was 40.00% in TCG. Additionally, the number of cough symptoms decreased from 9 to 3 and dyspnea from 4 to 2 in the TIG.Conclusion After high-intensity exercise, athletes with EIB achieved significant improvements in lung function and blood inflammatory factors by combining tangeretin and whey protein supplementation. EIB athletes also showed longer exercise endurance and VO2max at 4 weeks after TI. In addition, some patient symptoms disappeared after combination supplementation. The effect of this treatment on professional athletes with EIB was beneficial.https://www.tandfonline.com/doi/10.1080/15502783.2024.2414870Tangeretinexercise-induced bronchoconstrictionairway inflammationlung functionrespiratory symptomVO2max |
| spellingShingle | Zhi Cao Can Zhao Shiwei Mo Bing-Hong Gao Meng Liu The impact of tangeretin combined with whey protein on exercise-induced bronchoconstriction in professional athletes: a placebo-controlled trial Journal of the International Society of Sports Nutrition Tangeretin exercise-induced bronchoconstriction airway inflammation lung function respiratory symptom VO2max |
| title | The impact of tangeretin combined with whey protein on exercise-induced bronchoconstriction in professional athletes: a placebo-controlled trial |
| title_full | The impact of tangeretin combined with whey protein on exercise-induced bronchoconstriction in professional athletes: a placebo-controlled trial |
| title_fullStr | The impact of tangeretin combined with whey protein on exercise-induced bronchoconstriction in professional athletes: a placebo-controlled trial |
| title_full_unstemmed | The impact of tangeretin combined with whey protein on exercise-induced bronchoconstriction in professional athletes: a placebo-controlled trial |
| title_short | The impact of tangeretin combined with whey protein on exercise-induced bronchoconstriction in professional athletes: a placebo-controlled trial |
| title_sort | impact of tangeretin combined with whey protein on exercise induced bronchoconstriction in professional athletes a placebo controlled trial |
| topic | Tangeretin exercise-induced bronchoconstriction airway inflammation lung function respiratory symptom VO2max |
| url | https://www.tandfonline.com/doi/10.1080/15502783.2024.2414870 |
| work_keys_str_mv | AT zhicao theimpactoftangeretincombinedwithwheyproteinonexerciseinducedbronchoconstrictioninprofessionalathletesaplacebocontrolledtrial AT canzhao theimpactoftangeretincombinedwithwheyproteinonexerciseinducedbronchoconstrictioninprofessionalathletesaplacebocontrolledtrial AT shiweimo theimpactoftangeretincombinedwithwheyproteinonexerciseinducedbronchoconstrictioninprofessionalathletesaplacebocontrolledtrial AT binghonggao theimpactoftangeretincombinedwithwheyproteinonexerciseinducedbronchoconstrictioninprofessionalathletesaplacebocontrolledtrial AT mengliu theimpactoftangeretincombinedwithwheyproteinonexerciseinducedbronchoconstrictioninprofessionalathletesaplacebocontrolledtrial AT zhicao impactoftangeretincombinedwithwheyproteinonexerciseinducedbronchoconstrictioninprofessionalathletesaplacebocontrolledtrial AT canzhao impactoftangeretincombinedwithwheyproteinonexerciseinducedbronchoconstrictioninprofessionalathletesaplacebocontrolledtrial AT shiweimo impactoftangeretincombinedwithwheyproteinonexerciseinducedbronchoconstrictioninprofessionalathletesaplacebocontrolledtrial AT binghonggao impactoftangeretincombinedwithwheyproteinonexerciseinducedbronchoconstrictioninprofessionalathletesaplacebocontrolledtrial AT mengliu impactoftangeretincombinedwithwheyproteinonexerciseinducedbronchoconstrictioninprofessionalathletesaplacebocontrolledtrial |